Ang II is produced primarily in the epithelial cells of the lung and has therapeutic modalities commonly used to treat patients with high blood pressure by enhancing invasion and MMP production in lung cancer cells (Feng et al., 2011; Ishikane and Takahashi-Yanaga, 2018). Here, AGT is linked to lung carcinoma.